Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Invigor Medical vs yourEra

Invigor Medical
Graded #15

Higher grade

vs+2.299999999999997
yourEra
Graded #13

Lower grade

The verdict

Invigor Medical takes it — 86.1/100 to 83.8/100.

Invigor Medical grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. An established pharmacy operator with steady mid-market pricing and a broad catalog.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueInvigor Medical +2
84
82
Dose & formulationInvigor Medical +2
84
82
Clinical oversightInvigor Medical +3
88
85
Labs & monitoringInvigor Medical +1
86
85
FulfillmentInvigor Medical +2
88
86
Contract termsInvigor Medical +5
90
85
Invigor Medical · left baryourEra · right bar

The numbers

MetricInvigor MedicalyourEra
WeighScore86.1/10083.8/100
GradeBB
Scorecard rank#15#13
Semaglutide$199/mo$199/mo
Tirzepatide$339/mo$299/mo
CoverageNot disclosedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Invigor Medical

Graded #15 · B

Strengths

  • Mid-market pricing on both molecules
  • Long-running operator

Where it loses points

  • No explicit states list
  • Compounded only
yourEra

Graded #13 · B

Strengths

  • Transparent, publicly listed pricing — many compounded competitors hide price behind a quiz
  • Both semaglutide and tirzepatide, not a single-drug menu, plus NAD+ and microdosing lines
  • Markets a 50-state licensed-clinician network; no insurance required, HSA/FSA accepted
  • Optional yourEra Optimum membership adds 1:1 coaching, a nutritionist, at-home lab draws and wearables

Where it loses points

  • Compounded semaglutide/tirzepatide are not FDA-approved (not the same as Wegovy/Ozempic/Zepbound)
  • Mid-market pricing ($199 sema / $299 tirz) — above the cheapest compounders
  • No brand-name lane and no oral route — weekly injectable only
  • Thin independent footprint; the 50-state and efficacy claims are self-reported

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard